BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16716577)

  • 1. [Neurofibromatosis type 1 complications in the pediatric age: follow-up of a hundred cases].
    Bonnemaison E; Roze-Abert B; Lorette G; Sirinelli D; Boscq M; Mazjoub S; De Courtivron B; Bonnard C; Despert F; Toutain A; Maheut-Lourmière J; Barthez MA; Castelnau P;
    Arch Pediatr; 2006 Jul; 13(7):1009-14. PubMed ID: 16716577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurofibromatosis type 1: a survey of 195 patients].
    Overweg-Plandsoen WC; Weersink RG; Sillevis Smitt JH; Fleury P; van Asperen CJ
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):624-9. PubMed ID: 9127578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurofibromatosis type 1 in childhood].
    Kongshaug N; Meyer B; Kolmannskog S
    Tidsskr Nor Laegeforen; 1999 Aug; 119(18):2653-7. PubMed ID: 10479978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurofibromatosis in children. Our experience].
    López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
    Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eye disorders in neurofibromatosis (NF1).
    Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
    Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic outcome in children with multiple café au lait spots.
    Korf BR
    Pediatrics; 1992 Dec; 90(6):924-7. PubMed ID: 1344978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biology and management of laryngeal neurofibroma.
    Rahbar R; Litrovnik BG; Vargas SO; Robson CD; Nuss RC; Irons MB; McGill TJ; Healy GB
    Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1400-6. PubMed ID: 15611399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases.
    Wolkenstein P; Rodriguez D; Ferkal S; Gravier H; Buret V; Algans N; Simeoni MC; Bastuji-Garin S
    Br J Dermatol; 2009 Apr; 160(4):844-8. PubMed ID: 19067713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurofibromatosis type 1 in children].
    Lund AM; Skovby F
    Ugeskr Laeger; 1994 May; 156(21):3180-2. PubMed ID: 8066837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies.
    Cambiaghi S; Restano L; Caputo R
    Pediatr Dermatol; 2004; 21(2):97-101. PubMed ID: 15078345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral arteriopathy in children with neurofibromatosis type 1.
    Rea D; Brandsema JF; Armstrong D; Parkin PC; deVeber G; MacGregor D; Logan WJ; Askalan R
    Pediatrics; 2009 Sep; 124(3):e476-83. PubMed ID: 19706560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurofibromatosis type 1--own experiences].
    Czajkowski G; Kałuzny J; Jatczak-Gaca A; Wysocki M
    Klin Oczna; 2010; 112(1-3):45-8. PubMed ID: 20572503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Academic impairment is the most frequent complication of neurofibromatosis type-1 (NF1) in children.
    Coudé FX; Mignot C; Lyonnet S; Munnich A
    Behav Genet; 2006 Sep; 36(5):660-4. PubMed ID: 16474913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Type 1 neurofibromatosis in Tunisia: 66 cases].
    Gouider R; Azaiz MI; Kchouk M; Lasram L; Ben Osman A; Mrabet A
    Ann Dermatol Venereol; 1994; 121(2):185-9. PubMed ID: 7979037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic significance of unilateral Lisch nodules.
    Ceuterick SD; Van Den Ende JJ; Smets RM
    Bull Soc Belge Ophtalmol; 2005; (295):49-53. PubMed ID: 15849989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study of type 1 neurofibromatosis in north west England.
    McGaughran JM; Harris DI; Donnai D; Teare D; MacLeod R; Westerbeek R; Kingston H; Super M; Harris R; Evans DG
    J Med Genet; 1999 Mar; 36(3):197-203. PubMed ID: 10204844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.